{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T23:59:07Z","timestamp":1785542347305,"version":"3.56.0"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,1,4]],"date-time":"2021-01-04T00:00:00Z","timestamp":1609718400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,1,4]],"date-time":"2021-01-04T00:00:00Z","timestamp":1609718400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["17SDG33660072"],"award-info":[{"award-number":["17SDG33660072"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Nephrol"],"published-print":{"date-parts":[[2021,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Histone deacetylases (HDACs) are important epigenetic regulators that mediate deacetylation of both histone and non-histone proteins. HDACs, especially class I HDACs, are highly expressed in developing kidney and subject to developmental control. HDACs play an important role in kidney formation, especial nephron progenitor maintenance and differentiation. Several lines of evidence support the critical role of HDACs in the development and progression of various kidney diseases. HDAC inhibitors (HDACis) are very effective in the prevention and treatment of kidney diseases (including kidney cancer). A better understanting of the molecular mechanisms underlying the role(s) of HDACs in the pathogenesis and progression of renal disease are likely to be of great help in developing more effective and less toxic selective HDAC inhibitors and combinatorial therapeutics.<\/jats:p>","DOI":"10.1007\/s10157-020-01995-5","type":"journal-article","created":{"date-parts":[[2021,1,4]],"date-time":"2021-01-04T18:02:59Z","timestamp":1609783379000},"page":"215-223","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["The roles of histone deacetylases in kidney development and disease"],"prefix":"10.1007","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3411-4597","authenticated-orcid":false,"given":"Hongbing","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,4]]},"reference":[{"issue":"6990","key":"1995_CR1","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nature02625","volume":"429","author":"G Egger","year":"2004","unstructured":"Egger G, et al. Epigenetics in human disease and prospects for epigenetic therapy. Nature. 2004;429(6990):457\u201363.","journal-title":"Nature"},{"issue":"2","key":"1995_CR2","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nrg3142","volume":"13","author":"R Feil","year":"2012","unstructured":"Feil R, Fraga MF. Epigenetics and the environment: emerging patterns and implications. Nat Rev Genet. 2012;13(2):97\u2013109.","journal-title":"Nat Rev Genet"},{"issue":"Pt 1","key":"1995_CR3","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1242\/jeb.106971","volume":"218","author":"CJ Marsit","year":"2015","unstructured":"Marsit CJ. Influence of environmental exposure on human epigenetic regulation. J Exp Biol. 2015;218(Pt 1):71\u20139.","journal-title":"J Exp Biol"},{"key":"1995_CR4","doi-asserted-by":"publisher","DOI":"10.1242\/dev.153619","author":"H Liu","year":"2018","unstructured":"Liu H, et al. Histone deacetylases 1 and 2 regulate the transcriptional programs of nephron progenitors and renal vesicles. Development. 2018. https:\/\/doi.org\/10.1242\/dev.153619.","journal-title":"Development"},{"issue":"10","key":"1995_CR5","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/nrg2205","volume":"8","author":"A Schedl","year":"2007","unstructured":"Schedl A. Renal abnormalities and their developmental origin. Nat Rev Genet. 2007;8(10):791\u2013802.","journal-title":"Nat Rev Genet"},{"issue":"1","key":"1995_CR6","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1152\/japplphysiol.00068.2010","volume":"109","author":"O Aguilera","year":"2010","unstructured":"Aguilera O, et al. Epigenetics and environment: a complex relationship. J Appl Physiol (1985). 2010;109(1):243\u201351.","journal-title":"J Appl Physiol (1985)"},{"issue":"10","key":"1995_CR7","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1093\/ndt\/gfu026","volume":"29","author":"P Beckerman","year":"2014","unstructured":"Beckerman P, Ko YA, Susztak K. Epigenetics: a new way to look at kidney diseases. Nephrol Dial Transplant. 2014;29(10):1821\u20137.","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"1995_CR8","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s00441-017-2588-x","volume":"369","author":"N Wanner","year":"2017","unstructured":"Wanner N, Bechtel-Walz W. Epigenetics of kidney disease. Cell Tissue Res. 2017;369(1):75\u201392.","journal-title":"Cell Tissue Res"},{"key":"1995_CR9","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.semcdb.2018.08.014","volume":"91","author":"SS El-Dahr","year":"2019","unstructured":"El-Dahr SS, Saifudeen Z. Epigenetic regulation of renal development. Semin Cell Dev Biol. 2019;91:111\u20138.","journal-title":"Semin Cell Dev Biol"},{"issue":"2","key":"1995_CR10","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/s41576-018-0074-2","volume":"20","author":"M Berdasco","year":"2019","unstructured":"Berdasco M, Esteller M. Clinical epigenetics: seizing opportunities for translation. Nat Rev Genet. 2019;20(2):109\u201327.","journal-title":"Nat Rev Genet"},{"issue":"5\u20136","key":"1995_CR11","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1007\/PL00000896","volume":"58","author":"S Timmermann","year":"2001","unstructured":"Timmermann S, et al. Histone acetylation and disease. Cell Mol Life Sci CMLS. 2001;58(5\u20136):728\u201336.","journal-title":"Cell Mol Life Sci CMLS"},{"issue":"1","key":"1995_CR12","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/nrg2485","volume":"10","author":"M Haberland","year":"2009","unstructured":"Haberland M, Montgomery RL, Olson EN. The many roles of histone deacetylases in development and physiology: implications for disease and therapy. Nat Rev Genet. 2009;10(1):32\u201342.","journal-title":"Nat Rev Genet"},{"issue":"4","key":"1995_CR13","doi-asserted-by":"crossref","first-page":"a018713","DOI":"10.1101\/cshperspect.a018713","volume":"6","author":"E Seto","year":"2014","unstructured":"Seto E, Yoshida M. Erasers of histone acetylation: the histone deacetylase enzymes. Cold Spring Harbor Perspect Biol. 2014;6(4):a018713.","journal-title":"Cold Spring Harbor Perspect Biol"},{"issue":"3","key":"1995_CR14","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1042\/BST20130010","volume":"41","author":"RD Kelly","year":"2013","unstructured":"Kelly RD, Cowley SM. The physiological roles of histone deacetylase (HDAC) 1 and 2: complex co-stars with multiple leading parts. Biochem Soc Trans. 2013;41(3):741\u20139.","journal-title":"Biochem Soc Trans"},{"issue":"6","key":"1995_CR15","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1128\/MCB.24.6.2364-2372.2004","volume":"24","author":"M Vermeulen","year":"2004","unstructured":"Vermeulen M, et al. In vitro targeting reveals intrinsic histone tail specificity of the Sin3\/histone deacetylase and N-CoR\/SMRT corepressor complexes. Mol Cell Biol. 2004;24(6):2364\u201372.","journal-title":"Mol Cell Biol"},{"issue":"12","key":"1995_CR16","doi-asserted-by":"crossref","first-page":"5106","DOI":"10.1128\/MCB.24.12.5106-5118.2004","volume":"24","author":"X Zhang","year":"2004","unstructured":"Zhang X, et al. Activation of the growth-differentiation factor 11 gene by the histone deacetylase (HDAC) inhibitor trichostatin A and repression by HDAC3. Mol Cell Biol. 2004;24(12):5106\u201318.","journal-title":"Mol Cell Biol"},{"key":"1995_CR17","doi-asserted-by":"crossref","first-page":"129383","DOI":"10.1155\/2011\/129383","volume":"2011","author":"T Hayakawa","year":"2011","unstructured":"Hayakawa T, Nakayama J. Physiological roles of class I HDAC complex and histone demethylase. J Biomed Biotechnol. 2011;2011:129383.","journal-title":"J Biomed Biotechnol"},{"issue":"50","key":"1995_CR18","doi-asserted-by":"crossref","first-page":"47733","DOI":"10.1074\/jbc.M105590200","volume":"276","author":"MK Pflum","year":"2001","unstructured":"Pflum MK, et al. Histone deacetylase 1 phosphorylation promotes enzymatic activity and complex formation. J Biol Chem. 2001;276(50):47733\u201341.","journal-title":"J Biol Chem"},{"issue":"35","key":"1995_CR19","doi-asserted-by":"crossref","first-page":"31826","DOI":"10.1074\/jbc.M204149200","volume":"277","author":"SC Tsai","year":"2002","unstructured":"Tsai SC, Seto E. Regulation of histone deacetylase 2 by protein kinase CK2. J Biol Chem. 2002;277(35):31826\u201333.","journal-title":"J Biol Chem"},{"issue":"22","key":"1995_CR20","doi-asserted-by":"crossref","first-page":"19618","DOI":"10.1074\/jbc.M201174200","volume":"277","author":"SC Galasinski","year":"2002","unstructured":"Galasinski SC, et al. Phosphatase inhibition leads to histone deacetylases 1 and 2 phosphorylation and disruption of corepressor interactions. J Biol Chem. 2002;277(22):19618\u201326.","journal-title":"J Biol Chem"},{"issue":"7","key":"1995_CR21","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/s12276-018-0121-2","volume":"50","author":"S Yoon","year":"2018","unstructured":"Yoon S, et al. PP2A negatively regulates the hypertrophic response by dephosphorylating HDAC2 S394 in the heart. Exp Mol Med. 2018;50(7):83.","journal-title":"Exp Mol Med"},{"issue":"14","key":"1995_CR22","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1101\/gad.1563807","volume":"21","author":"RL Montgomery","year":"2007","unstructured":"Montgomery RL, et al. Histone deacetylases 1 and 2 redundantly regulate cardiac morphogenesis, growth, and contractility. Genes Dev. 2007;21(14):1790\u2013802.","journal-title":"Genes Dev"},{"issue":"37","key":"1995_CR23","doi-asserted-by":"crossref","first-page":"32775","DOI":"10.1074\/jbc.M111.248278","volume":"286","author":"S Chen","year":"2011","unstructured":"Chen S, et al. Histone deacetylase (HDAC) activity is critical for embryonic kidney gene expression, growth, and differentiation. J Biol Chem. 2011;286(37):32775\u201389.","journal-title":"J Biol Chem"},{"issue":"4","key":"1995_CR24","first-page":"565","volume":"89","author":"SA Hilliard","year":"2016","unstructured":"Hilliard SA, El-Dahr SS. Epigenetics of renal development and disease. Yale J Biol Med. 2016;89(4):565\u201373.","journal-title":"Yale J Biol Med"},{"key":"1995_CR25","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1159\/000505295","volume":"6","author":"L Nie","year":"2020","unstructured":"Nie L, Young L, Zhang B, Zhao J. Application of histone deacetylase inhibitors in renal interstitial fibrosis. Kidney Dis. 2020;6:226\u201335.","journal-title":"Kidney Dis"},{"issue":"2\u20133","key":"1995_CR26","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1387\/ijdb.082649rb","volume":"53","author":"R Brunmeir","year":"2009","unstructured":"Brunmeir R, Lagger S, Seiser C. Histone deacetylase HDAC1\/HDAC2-controlled embryonic development and cell differentiation. Int J Dev Biol. 2009;53(2\u20133):275\u201389.","journal-title":"Int J Dev Biol"},{"issue":"6","key":"1995_CR27","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1242\/dev.113506","volume":"142","author":"S Chen","year":"2015","unstructured":"Chen S, et al. Histone deacetylase 1 and 2 regulate Wnt and p53 pathways in the ureteric bud epithelium. Development. 2015;142(6):1180\u201392.","journal-title":"Development"},{"issue":"1","key":"1995_CR28","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1093\/jmcb\/mjx005","volume":"9","author":"S El-Dahr","year":"2017","unstructured":"El-Dahr S, Hilliard S, Saifudeen Z. Regulation of kidney development by the Mdm2\/Mdm4-p53 axis. J Mol Cell Biol. 2017;9(1):26\u201333.","journal-title":"J Mol Cell Biol"},{"issue":"23","key":"1995_CR29","doi-asserted-by":"crossref","first-page":"3863","DOI":"10.1242\/dev.034876","volume":"136","author":"GR Dressler","year":"2009","unstructured":"Dressler GR. Advances in early kidney specification, development and patterning. Development. 2009;136(23):3863\u201374.","journal-title":"Development"},{"issue":"2","key":"1995_CR30","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.stem.2008.05.020","volume":"3","author":"A Kobayashi","year":"2008","unstructured":"Kobayashi A, et al. Six2 defines and regulates a multipotent self-renewing nephron progenitor population throughout mammalian kidney development. Cell Stem Cell. 2008;3(2):169\u201381.","journal-title":"Cell Stem Cell"},{"key":"1995_CR31","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a008300","author":"MH Little","year":"2012","unstructured":"Little MH, McMahon AP. Mammalian kidney development: principles, progress, and projections. Cold Spring Harb Perspect Biol. 2012. https:\/\/doi.org\/10.1101\/cshperspect.a008300.","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"web server issu","key":"1995_CR32","doi-asserted-by":"crossref","first-page":"W376","DOI":"10.1093\/nar\/gks437","volume":"40","author":"L Wang","year":"2012","unstructured":"Wang L, et al. ASEB: a web server for KAT-specific acetylation site prediction. Nucleic Acids Res. 2012;40(web server issue):W376\u20139.","journal-title":"Nucleic Acids Res"},{"issue":"10","key":"1995_CR33","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/j.mod.2004.05.019","volume":"121","author":"S Brodbeck","year":"2004","unstructured":"Brodbeck S, Besenbeck B, Englert C. The transcription factor Six2 activates expression of the Gdnf gene as well as its own promoter. Mech Dev. 2004;121(10):1211\u201322.","journal-title":"Mech Dev"},{"key":"1995_CR34","doi-asserted-by":"publisher","DOI":"10.1242\/bio.042754","author":"S Hilliard","year":"2019","unstructured":"Hilliard S, et al. Defining the dynamic chromatin landscape of mouse nephron progenitors. Biol Open. 2019. https:\/\/doi.org\/10.1242\/bio.042754.","journal-title":"Biol Open"},{"issue":"4","key":"1995_CR35","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.stemcr.2014.08.008","volume":"3","author":"A Kobayashi","year":"2014","unstructured":"Kobayashi A, et al. Identification of a multipotent self-renewing stromal progenitor population during mammalian kidney organogenesis. Stem Cell Rep. 2014;3(4):650\u201362.","journal-title":"Stem Cell Rep"},{"issue":"1","key":"1995_CR36","doi-asserted-by":"crossref","first-page":"85","DOI":"10.2353\/ajpath.2010.090517","volume":"176","author":"BD Humphreys","year":"2010","unstructured":"Humphreys BD, et al. Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis. Am J Pathol. 2010;176(1):85\u201397.","journal-title":"Am J Pathol"},{"key":"1995_CR37","doi-asserted-by":"crossref","first-page":"15676","DOI":"10.1038\/srep15676","volume":"5","author":"T Ohmori","year":"2015","unstructured":"Ohmori T, et al. Sall1 in renal stromal progenitors non-cell autonomously restricts the excessive expansion of nephron progenitors. Sci Rep. 2015;5:15676.","journal-title":"Sci Rep"},{"issue":"2","key":"1995_CR38","doi-asserted-by":"crossref","first-page":"e88400","DOI":"10.1371\/journal.pone.0088400","volume":"9","author":"S Hum","year":"2014","unstructured":"Hum S, et al. Ablation of the renal stroma defines its critical role in nephron progenitor and vasculature patterning. PLoS ONE. 2014;9(2):e88400.","journal-title":"PLoS ONE"},{"key":"1995_CR39","first-page":"121","volume":"6","author":"N Liu","year":"2015","unstructured":"Liu N, Zhuang S. Treatment of chronic kidney diseases with histone deacetylase inhibitors. Front Physiol. 2015;6:121.","journal-title":"Front Physiol"},{"issue":"6","key":"1995_CR40","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1681\/ASN.2012111055","volume":"24","author":"C Cianciolo Cosentino","year":"2013","unstructured":"Cianciolo Cosentino C, et al. Histone deacetylase inhibitor enhances recovery after AKI. J Am Soc Nephrol JASN. 2013;24(6):943\u201353.","journal-title":"J Am Soc Nephrol JASN"},{"issue":"4","key":"1995_CR41","doi-asserted-by":"crossref","first-page":"F996","DOI":"10.1152\/ajprenal.00282.2009","volume":"297","author":"M Pang","year":"2009","unstructured":"Pang M, et al. Inhibition of histone deacetylase activity attenuates renal fibroblast activation and interstitial fibrosis in obstructive nephropathy. Am J Physiol Renal Physiol. 2009;297(4):F996\u20131005.","journal-title":"Am J Physiol Renal Physiol"},{"issue":"8","key":"1995_CR42","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1002\/jcb.23135","volume":"112","author":"M Pang","year":"2011","unstructured":"Pang M, et al. Histone deacetylase 1\/2 mediates proliferation of renal interstitial fibroblasts and expression of cell cycle proteins. J Cell Biochem. 2011;112(8):2138\u201348.","journal-title":"J Cell Biochem"},{"issue":"10","key":"1995_CR43","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1634\/stemcells.2007-0049","volume":"25","author":"N Imai","year":"2007","unstructured":"Imai N, et al. Inhibition of histone deacetylase activates side population cells in kidney and partially reverses chronic renal injury. Stem Cells. 2007;25(10):2469\u201375.","journal-title":"Stem Cells"},{"issue":"1","key":"1995_CR44","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.juro.2013.06.110","volume":"191","author":"SR Manson","year":"2014","unstructured":"Manson SR, et al. HDAC dependent transcriptional repression of Bmp-7 potentiates TGF-beta mediated renal fibrosis in obstructive uropathy. J Urol. 2014;191(1):242\u201352.","journal-title":"J Urol"},{"issue":"1","key":"1995_CR45","doi-asserted-by":"crossref","first-page":"e54001","DOI":"10.1371\/journal.pone.0054001","volume":"8","author":"N Liu","year":"2013","unstructured":"Liu N, et al. Blocking the class I histone deacetylase ameliorates renal fibrosis and inhibits renal fibroblast activation via modulating TGF-beta and EGFR signaling. PLoS ONE. 2013;8(1):e54001.","journal-title":"PLoS ONE"},{"key":"1995_CR46","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.phrs.2019.02.011","volume":"142","author":"M Yang","year":"2019","unstructured":"Yang M, et al. Inhibition of class I HDACs attenuates renal interstitial fibrosis in a murine model. Pharmacol Res. 2019;142:192\u2013204.","journal-title":"Pharmacol Res"},{"key":"1995_CR47","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19092630","author":"MJ Hadden","year":"2018","unstructured":"Hadden MJ, Advani A. Histone deacetylase inhibitors and diabetic kidney disease. Int J Mol Sci. 2018. https:\/\/doi.org\/10.3390\/ijms19092630.","journal-title":"Int J Mol Sci"},{"issue":"12","key":"1995_CR48","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1038\/ki.2011.39","volume":"79","author":"RE Gilbert","year":"2011","unstructured":"Gilbert RE, et al. Histone deacetylase inhibition attenuates diabetes-associated kidney growth: potential role for epigenetic modification of the epidermal growth factor receptor. Kidney Int. 2011;79(12):1312\u201321.","journal-title":"Kidney Int"},{"issue":"5","key":"1995_CR49","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1016\/j.ajpath.2011.01.044","volume":"178","author":"A Advani","year":"2011","unstructured":"Advani A, et al. Long-term administration of the histone deacetylase inhibitor vorinostat attenuates renal injury in experimental diabetes through an endothelial nitric oxide synthase-dependent mechanism. Am J Pathol. 2011;178(5):2205\u201314.","journal-title":"Am J Pathol"},{"issue":"3","key":"1995_CR50","doi-asserted-by":"crossref","first-page":"F729","DOI":"10.1152\/ajprenal.00086.2009","volume":"297","author":"H Noh","year":"2009","unstructured":"Noh H, et al. Histone deacetylase-2 is a key regulator of diabetes- and transforming growth factor-beta1-induced renal injury. Am J Physiol Renal Physiol. 2009;297(3):F729\u201339.","journal-title":"Am J Physiol Renal Physiol"},{"issue":"20","key":"1995_CR51","doi-asserted-by":"crossref","first-page":"32655","DOI":"10.18632\/oncotarget.15948","volume":"8","author":"Z Xu","year":"2017","unstructured":"Xu Z, et al. EGFR inhibition attenuates diabetic nephropathy through decreasing ROS and endoplasmic reticulum stress. Oncotarget. 2017;8(20):32655\u201367.","journal-title":"Oncotarget"},{"issue":"3","key":"1995_CR52","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1172\/JCI124030","volume":"129","author":"K Inoue","year":"2019","unstructured":"Inoue K, et al. Podocyte histone deacetylase activity regulates murine and human glomerular diseases. J Clin Investig. 2019;129(3):1295\u2013313.","journal-title":"J Clin Investig"},{"issue":"5","key":"1995_CR53","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1053\/j.seminoncol.2006.06.005","volume":"33","author":"KM Jacobsohn","year":"2006","unstructured":"Jacobsohn KM, Wood CG. Adjuvant therapy for renal cell carcinoma. Semin Oncol. 2006;33(5):576\u201382.","journal-title":"Semin Oncol"},{"key":"1995_CR54","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1186\/1471-2407-8-381","volume":"8","author":"FR Fritzsche","year":"2008","unstructured":"Fritzsche FR, et al. Class I histone deacetylases 1, 2 and 3 are highly expressed in renal cell cancer. BMC Cancer. 2008;8:381.","journal-title":"BMC Cancer"},{"issue":"7","key":"1995_CR55","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1007\/s00204-018-2229-5","volume":"92","author":"N Kiweler","year":"2018","unstructured":"Kiweler N, et al. The histone deacetylases HDAC1 and HDAC2 are required for the growth and survival of renal carcinoma cells. Arch Toxicol. 2018;92(7):2227\u201343.","journal-title":"Arch Toxicol"},{"key":"1995_CR56","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1186\/s12885-016-2604-7","volume":"16","author":"S Ramakrishnan","year":"2016","unstructured":"Ramakrishnan S, et al. HDAC 1 and 6 modulate cell invasion and migration in clear cell renal cell carcinoma. BMC Cancer. 2016;16:617.","journal-title":"BMC Cancer"},{"issue":"10\u201312","key":"1995_CR57","first-page":"717","volume":"1799","author":"PA Marks","year":"2010","unstructured":"Marks PA. Histone deacetylase inhibitors: a chemical genetics approach to understanding cellular functions. Biochem Biophys Acta. 2010;1799(10\u201312):717\u201325.","journal-title":"Biochem Biophys Acta"},{"issue":"2","key":"1995_CR58","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1007\/s12272-017-0998-7","volume":"41","author":"P Chun","year":"2018","unstructured":"Chun P. Therapeutic effects of histone deacetylase inhibitors on kidney disease. Arch Pharmacal Res. 2018;41(2):162\u201383.","journal-title":"Arch Pharmacal Res"},{"issue":"8B","key":"1995_CR59","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1111\/j.1582-4934.2008.00436.x","volume":"13","author":"J Jones","year":"2009","unstructured":"Jones J, et al. The histone deacetylase inhibitor valproic acid alters growth properties of renal cell carcinoma in vitro and in vivo. J Cell Mol Med. 2009;13(8B):2376\u201385.","journal-title":"J Cell Mol Med"},{"issue":"3","key":"1995_CR60","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1158\/1078-0432.CCR-08-1918","volume":"15","author":"TL Cha","year":"2009","unstructured":"Cha TL, et al. Dual degradation of aurora A and B kinases by the histone deacetylase inhibitor LBH589 induces G2-M arrest and apoptosis of renal cancer cells. Clin Cancer Res. 2009;15(3):840\u201350.","journal-title":"Clin Cancer Res"},{"issue":"10","key":"1995_CR61","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1248\/bpb.32.1723","volume":"32","author":"HK Kwon","year":"2009","unstructured":"Kwon HK, et al. A novel gamma-lactam-based histone deacetylase inhibitor potently inhibits the growth of human breast and renal cancer cells. Biol Pharm Bull. 2009;32(10):1723\u20137.","journal-title":"Biol Pharm Bull"},{"key":"1995_CR62","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3389\/fonc.2018.00092","volume":"8","author":"A Suraweera","year":"2018","unstructured":"Suraweera A, O\u2019Byrne KJ, Richard DJ. Combination therapy with histone deacetylase inhibitors (HDACi) for the treatment of cancer: achieving the full therapeutic potential of HDACi. Front Oncology. 2018;8:92.","journal-title":"Front Oncology"},{"issue":"1","key":"1995_CR63","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.canlet.2012.05.003","volume":"324","author":"E Juengel","year":"2012","unstructured":"Juengel E, et al. Acetylation of histone H3 prevents resistance development caused by chronic mTOR inhibition in renal cell carcinoma cells. Cancer Lett. 2012;324(1):83\u201390.","journal-title":"Cancer Lett"},{"issue":"23","key":"1995_CR64","doi-asserted-by":"crossref","first-page":"7199","DOI":"10.1158\/1078-0432.CCR-17-1178","volume":"23","author":"R Pili","year":"2017","unstructured":"Pili R, et al. Immunomodulation by entinostat in renal cell carcinoma patients receiving high-dose interleukin 2: a multicenter, single-arm, phase I\/II Trial (NCI-CTEP#7870). Clin Cancer Res. 2017a;23(23):7199\u2013208.","journal-title":"Clin Cancer Res"},{"issue":"7","key":"1995_CR65","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1038\/bjc.2017.33","volume":"116","author":"R Pili","year":"2017","unstructured":"Pili R, et al. Combination of the histone deacetylase inhibitor vorinostat with bevacizumab in patients with clear-cell renal cell carcinoma: a multicentre, single-arm phase I\/II clinical trial. Br J Cancer. 2017b;116(7):874\u201383.","journal-title":"Br J Cancer"}],"container-title":["Clinical and Experimental Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-020-01995-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10157-020-01995-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-020-01995-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,2]],"date-time":"2021-03-02T15:41:10Z","timestamp":1614699670000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10157-020-01995-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,4]]},"references-count":65,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["1995"],"URL":"https:\/\/doi.org\/10.1007\/s10157-020-01995-5","relation":{},"ISSN":["1342-1751","1437-7799"],"issn-type":[{"value":"1342-1751","type":"print"},{"value":"1437-7799","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,4]]},"assertion":[{"value":"17 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}